FDA Adverse Event Injury Summary report: N

FINELINE II

MDR report key: 3053167 · Received April 11, 2013

Report

Report Number
2124215-2013-05634
Event Type
Injury
Date Received
April 11, 2013
Date of Event
December 1, 2012
Report Date
March 12, 2013
Manufacturer
CPI - DEL CARIBE
Product Code
NVN
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

AS NO FURTHER INFORMATION CONCERNING THIS REPORT IS EXPECTED, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THIS RIGHT ATRIAL (RA) LEAD EXHIBITED NOISE AND OUT-OF-RANGE (OOR) PACING IMPEDANCES > 2000 OHMS. SURGICAL INTERVENTION WAS PERFORMED WHERE THE LEAD WAS SURGICALLY ABANDONED AND A NEW RA LEAD WAS IMPLANTED. NO ADVERSE PATIENT EFFECTS WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
155227 FINELINE II IMPLANTABLE LEAD NVN CPI - DEL CARIBE 4470

Patients

Seq Age Sex Outcome Treatment
1 82 YR Hospitalization| L| R E110| A135| 4470| 0158